Improvement of peripheral neuropathy in a patient with antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis by additional mepolizumab

BACKGROUND: Eosinophilic granulomatosis with polyangiitis (EGPA) is a vasculitis characterized by abnormally high eosinophils and frequent peripheral neuropathy. Mepolizumab is an approved therapy for EGPA, but its efficacy against peripheral neuropathy remains unknown. CASE PRESENTATION: A 41-year-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kai, Yoshiro, Yoshikawa, Masanori, Matsuda, Masayuki, Suzuki, Kentaro, Ohara, Hiroya, Iguchi, Naohiko, Kasamatsu, Takehito, Uno, Kenji, Fujioka, Nobuhiro, Fujita, Yukio, Muro, Shigeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858463/
https://www.ncbi.nlm.nih.gov/pubmed/35183225
http://dx.doi.org/10.1186/s13223-022-00653-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858463/
https://www.ncbi.nlm.nih.gov/pubmed/35183225
http://dx.doi.org/10.1186/s13223-022-00653-7

Ejemplares similares